ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $23,340,000 | +39.1% | 135,593 | +1.4% | 0.01% | +60.0% |
| Q2 2021 | $16,774,000 | -1.3% | 133,679 | +6.6% | 0.01% | -16.7% |
| Q1 2021 | $16,998,000 | +30.1% | 125,368 | +22.8% | 0.01% | +20.0% |
| Q4 2020 | $13,067,000 | +17.2% | 102,131 | +3.1% | 0.01% | 0.0% |
| Q3 2020 | $11,150,000 | -35.2% | 99,081 | -45.1% | 0.01% | -37.5% |
| Q2 2020 | $17,204,000 | +18.5% | 180,565 | +11.7% | 0.01% | 0.0% |
| Q1 2020 | $14,524,000 | +125.3% | 161,723 | +33.0% | 0.01% | +300.0% |
| Q4 2019 | $6,446,000 | +56.3% | 121,584 | +16.5% | 0.00% | 0.0% |
| Q3 2019 | $4,124,000 | +138.9% | 104,335 | +148.3% | 0.00% | +100.0% |
| Q2 2019 | $1,726,000 | – | 42,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |